Skip to content

Pamela Miller

Holland Bloorview Kids Rehabilitation Hospital/Speech Language Pathologist

2023 Salary — last year on the list

$100,509

Total compensation $100,829, including $320 in taxable benefits.

Source: Ontario’s Public Sector Salary Disclosure — names paid $100,000 or more that year. How we build this · Report an error on this page

At a Glance
2023

Employer Rank

#209

Holland Bloorview Kids Rehabilitation Hospital

Years on List

1

2023–2023

Peak Salary

$100,509

2023

Full 2023 roster at Holland Bloorview Kids Rehabilitation Hospital →·See where $100,509 ranks →

Full History
2023–2023

Full salary history, by year
YearPositionSalary
2023Speech Language PathologistHolland Bloorview Kids Rehabilitation Hospital$100,509Benefits $320Total $100,829

Take-Home Pay
(After Tax) · 2023 estimate

In 2023, Pamela Miller's $100,509 salary works out to roughly $73,990 after income tax, CPP and EI — an all-in deduction rate of about 26.4%. Within Holland Bloorview Kids Rehabilitation Hospital, Pamela Miller's total compensation of $100,829 was the #209 of 213, against a median salary of $114,671. This is Pamela Miller's first appearance on the Sunshine List. Most Hospitals & Boards of Public Health employees belong to HOOPP, so actual take-home is likely another 7–10% lower after pension contributions.

Estimated net pay
~$73,990
Effective income-tax rate (excl. CPP/EI)
~21.7%
CPP + EI contributions
~$4,756
All-in deduction rate (incl. CPP/EI)
~26.4%
vs. 2023 Speech Language Pathologist median
−7%

Where does $100,509 rank on the Sunshine List? →

Estimate only: 2023 federal and Ontario rates, basic personal amounts, Canada employment amount and CPP/EI credits; single, employment income only, salary treated as full-year income. Ignores pension contributions (OMERS, HOOPP, OTPP, OPTrust and similar plans lower actual take-home), union dues, RRSPs and benefits.

Also at Holland Bloorview Kids Rehabilitation Hospital
2023

View all 213 employees at Holland Bloorview Kids Rehabilitation Hospital (2023) →